» Articles » PMID: 8346247

NF-IL6-mediated Transcriptional Activation of the Long Terminal Repeat of the Human Immunodeficiency Virus Type 1

Overview
Specialty Science
Date 1993 Aug 1
PMID 8346247
Citations 39
Authors
Affiliations
Soon will be listed here.
Abstract

An upstream control region in the long terminal repeat (LTR) of human immunodeficiency virus type 1 (HIV-1) includes a potential negative regulatory element (NRE1). Cotransfecting multimers of a sequence spanning this element with an LTR-CAT construct produced an increase in chloramphenicol acetyltransferase (CAT) activity in Jurkat and HepG2 cells, providing further evidence and support for the existence of an NRE. In screening experiments aimed at identifying those factors that regulate HIV-1 transcription through interactions with the NRE1 region, we isolated a cDNA for NF-IL6. Previous studies have shown that NF-IL6 is a key nuclear factor that activates gene expression in response to interleukin 6. By methylation interference analysis, we have localized the NF-IL6 binding site within the NRE1 region and found that it overlaps an E box that has previously been implicated as the binding element for a negative regulator of HIV-1 expression. Through a database search, we identified an additional consensus binding sequence for NF-IL6 in the LTR of many HIV-1 variants and found that over this sequence, purified NF-IL6 can produce an extended footprint that overlaps one of the binding sites for NF-kappa B. A product of the nf-il6 gene activated transcription from several LTR-CAT constructs in transient transfection assays. Thus, NF-IL6 could play a central role in the control of HIV-1 gene expression and this protein might be a key mediator in signaling pathways where HIV-1 is activated by interleukin 6.

Citing Articles

Involvement of Human Cellular Proteins and Structures in Realization of the HIV Life Cycle: A Comprehensive Review, 2024.

Schemelev A, Davydenko V, Ostankova Y, Reingardt D, Serikova E, Zueva E Viruses. 2024; 16(11).

PMID: 39599797 PMC: 11599013. DOI: 10.3390/v16111682.


RPLP1 restricts HIV-1 transcription by disrupting C/EBPβ binding to the LTR.

Yang W, Wang H, Li Z, Zhang L, Liu J, Kirchhoff F Nat Commun. 2024; 15(1):5290.

PMID: 38906865 PMC: 11192919. DOI: 10.1038/s41467-024-49622-1.


IFNα and β Mediated JCPyV Suppression through C/EBPβ-LIP Isoform.

May D, Bellizzi A, Kassa W, Cipriaso J, Caocci M, Wollebo H Viruses. 2021; 13(10).

PMID: 34696366 PMC: 8537971. DOI: 10.3390/v13101937.


The E3 Ubiquitin-Protein Ligase Cullin 3 Regulates HIV-1 Transcription.

Langer S, Yin X, Diaz A, Portillo A, Gordon D, Rogers U Cells. 2020; 9(9).

PMID: 32882949 PMC: 7564853. DOI: 10.3390/cells9092010.


Safe CRISPR-Cas9 Inhibition of HIV-1 with High Specificity and Broad-Spectrum Activity by Targeting LTR NF-κB Binding Sites.

Chung C, Allen A, Atkins A, Sullivan N, Homan G, Costello R Mol Ther Nucleic Acids. 2020; 21:965-982.

PMID: 32818921 PMC: 7452136. DOI: 10.1016/j.omtn.2020.07.016.


References
1.
Vaishnav Y, Wong-Staal F . The biochemistry of AIDS. Annu Rev Biochem. 1991; 60:577-630. DOI: 10.1146/annurev.bi.60.070191.003045. View

2.
Rosenberg Z, Fauci A . Immunopathogenesis of HIV infection. FASEB J. 1991; 5(10):2382-90. DOI: 10.1096/fasebj.5.10.1676689. View

3.
Williams S, Cantwell C, Johnson P . A family of C/EBP-related proteins capable of forming covalently linked leucine zipper dimers in vitro. Genes Dev. 1991; 5(9):1553-67. DOI: 10.1101/gad.5.9.1553. View

4.
Descombes P, Schibler U . A liver-enriched transcriptional activator protein, LAP, and a transcriptional inhibitory protein, LIP, are translated from the same mRNA. Cell. 1991; 67(3):569-79. DOI: 10.1016/0092-8674(91)90531-3. View

5.
Giacca M, Gutierrez M, Menzo S, dAdda di Fagagna F, Falaschi A . A human binding site for transcription factor USF/MLTF mimics the negative regulatory element of human immunodeficiency virus type 1. Virology. 1992; 186(1):133-47. DOI: 10.1016/0042-6822(92)90067-y. View